Voyager Therapeutics (VYGR) Return on Sales (2015 - 2026)

Voyager Therapeutics has disclosed Return on Sales across 12 years of filings, most recently posting 0.11% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.11%, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03% (down 2.0% YoY), and the FY2025 annual result was 0.03%, down 2.0% from the prior year.
• Return on Sales came in at 0.11% for Q1 2026 at Voyager Therapeutics, down from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.15% in Q4 2022 to a low of 0.32% in Q1 2022.
• The 5-year median for Return on Sales is 0.02% (2025), against an average of 0.05%.
• Across the five-year window, Return on Sales slipped 28 bps in 2022 and jumped 33 bps in 2023, its largest moves.
• Voyager Therapeutics' Return on Sales stood at 0.15% in 2022, then sank by 96 bps to 0.01% in 2023, then sank by 975 bps to 0.05% in 2024, then jumped by 67 bps to 0.02% in 2025, then sank by 504 bps to 0.11% in 2026.
• The last three Return on Sales figures came in at 0.11% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.